232 related articles for article (PubMed ID: 16127052)
1. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G
Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
[TBL] [Abstract][Full Text] [Related]
2. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β.
Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M
J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
de Lucas S; Bartolome J; Carreno V
J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
[TBL] [Abstract][Full Text] [Related]
4. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
5. Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.
Boulestin A; Kamar N; Legrand-Abravanel F; Sandres-Saune K; Alric L; Vinel JP; Rostaing L; Izopet J
Antimicrob Agents Chemother; 2004 Sep; 48(9):3610-2. PubMed ID: 15328140
[TBL] [Abstract][Full Text] [Related]
6. Post HCV Infection Due to MX Gene Stimulation Produced Post Treatment with Imported and Locally Produced Egyptian Biosimilar IFN.
Mohamed SH; Mahmoud NF; Mohamed AF; Kotb NS
Asian Pac J Cancer Prev; 2015; 16(14):5635-41. PubMed ID: 26320428
[TBL] [Abstract][Full Text] [Related]
7. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
Shaker O; Ahmed A; Doss W; Abdel-Hamid M
J Viral Hepat; 2010 Nov; 17(11):794-9. PubMed ID: 20002306
[TBL] [Abstract][Full Text] [Related]
8. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon.
Berger Rentsch M; Zimmer G
PLoS One; 2011; 6(10):e25858. PubMed ID: 21998709
[TBL] [Abstract][Full Text] [Related]
9. Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon.
Fray MD; Mann GE; Charleston B
J Immunol Methods; 2001 Mar; 249(1-2):235-44. PubMed ID: 11226480
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins.
Fernández M; Quiroga JA; Carreño V
J Gen Virol; 2003 Aug; 84(Pt 8):2073-2082. PubMed ID: 12867637
[TBL] [Abstract][Full Text] [Related]
11. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of antiviral MxA protein in peripheral blood of patients with a chronic disease of unknown etiology.
Chieux V; Chehadeh W; Hautecoeur P; Harvey J; Wattré P; Hober D
J Med Virol; 2001 Oct; 65(2):301-8. PubMed ID: 11536237
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
14. A novel sensitive and selective bioassay for human type I interferons.
Files JG; Gray JL; Do LT; Foley WP; Gabe JD; Nestaas E; Pungor E
J Interferon Cytokine Res; 1998 Dec; 18(12):1019-24. PubMed ID: 9877444
[TBL] [Abstract][Full Text] [Related]
15. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription.
Choudhary S; Gao J; Leaman DW; De BP
J Virol; 2001 May; 75(10):4823-31. PubMed ID: 11312354
[TBL] [Abstract][Full Text] [Related]
16. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene.
Ronni T; Matikainen S; Lehtonen A; Palvimo J; Dellis J; Van Eylen F; Goetschy JF; Horisberger M; Content J; Julkunen I
J Interferon Cytokine Res; 1998 Sep; 18(9):773-81. PubMed ID: 9781817
[TBL] [Abstract][Full Text] [Related]
17. Virus free, cell-based assay for the quantification of murine type I interferons.
Bollati-Fogolín M; Müller W
J Immunol Methods; 2005 Nov; 306(1-2):169-75. PubMed ID: 16209875
[TBL] [Abstract][Full Text] [Related]
18. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL;
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795
[TBL] [Abstract][Full Text] [Related]
19. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
Hijikata M; Ohta Y; Mishiro S
Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
[TBL] [Abstract][Full Text] [Related]
20. Pegylation of IFN-alpha and antiviral activity.
Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
